| UniProt ID | FANCB_HUMAN | |
|---|---|---|
| UniProt AC | Q8NB91 | |
| Protein Name | Fanconi anemia group B protein | |
| Gene Name | FANCB | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 859 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | DNA repair protein required for FANCD2 ubiquitination.. | |
| Protein Sequence | MTSKQAMSSNEQERLLCYNGEVLVFQLSKGNFADKEPTKTPILHVRRMVFDRGTKVFVQKSTGFFTIKEENSHLKIMCCNCVSDFRTGINLPYIVIEKNKKNNVFEYFLLILHSTNKFEMRLSFKLGYEMKDGLRVLNGPLILWRHVKAFFFISSQTGKVVSVSGNFSSIQWAGEIENLGMVLLGLKECCLSEEECTQEPSKSDYAIWNTKFCVYSLESQEVLSDIYIIPPAYSSVVTYVHICATEIIKNQLRISLIALTRKNQLISFQNGTPKNVCQLPFGDPCAVQLMDSGGGNLFFVVSFISNNACAVWKESFQVAAKWEKLSLVLIDDFIGSGTEQVLLLFKDSLNSDCLTSFKITDLGKINYSSEPSDCNEDDLFEDKQENRYLVVPPLETGLKVCFSSFRELRQHLLLKEKIISKSYKALINLVQGKDDNTSSAEEKECLVPLCGEEENSVHILDEKLSDNFQDSEQLVEKIWYRVIDDSLVVGVKTTSSLKLSLNDVTLSLLMDQAHDSRFRLLKCQNRVIKLSTNPFPAPYLMPCEIGLEAKRVTLTPDSKKEESFVCEHPSKKECVQIITAVTSLSPLLTFSKFCCTVLLQIMERESGNCPKDRYVVCGRVFLSLEDLSTGKYLLTFPKKKPIEHMEDLFALLAAFHKSCFQITSPGYALNSMKVWLLEHMKCEIIKEFPEVYFCERPGSFYGTLFTWKQRTPFEGILIIYSRNQTVMFQCLHNLIRILPINCFLKNLKSGSENFLIDNMAFTLEKELVTLSSLSSAIAKHESNFMQRCEVSKGKSSVVAAALSDRRENIHPYRKELQREKKKMLQTNLKVSGALYREITLKVAEVQLKSDFAAQKLSNL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MTSKQAMSS ------CCCHHCCCC | 44.63 | 22814378 | |
| 4 | Ubiquitination | ----MTSKQAMSSNE ----CCCHHCCCCHH | 32.67 | - | |
| 39 | Ubiquitination | FADKEPTKTPILHVR CCCCCCCCCCEEEEE | 64.12 | - | |
| 68 | Ubiquitination | STGFFTIKEENSHLK CCCCEEEEECCCCEE | 56.79 | - | |
| 123 | Phosphorylation | NKFEMRLSFKLGYEM CCCEEEEEEECCCEE | 15.23 | 24719451 | |
| 202 | Ubiquitination | ECTQEPSKSDYAIWN HHCCCCCCCCCEEEE | 59.05 | - | |
| 205 | Phosphorylation | QEPSKSDYAIWNTKF CCCCCCCCEEEECCE | 13.69 | 25159151 | |
| 358 | Ubiquitination | SDCLTSFKITDLGKI CCCCEEEEEEECCCC | 44.45 | - | |
| 364 | Ubiquitination | FKITDLGKINYSSEP EEEEECCCCCCCCCC | 34.77 | - | |
| 383 | Ubiquitination | EDDLFEDKQENRYLV CCHHCCCCCCCCEEE | 52.92 | - | |
| 415 | Ubiquitination | LRQHLLLKEKIISKS HHHHHHHCHHHHCHH | 57.86 | - | |
| 421 | Ubiquitination | LKEKIISKSYKALIN HCHHHHCHHHHHHHH | 47.60 | - | |
| 424 | Ubiquitination | KIISKSYKALINLVQ HHHCHHHHHHHHHHC | 43.75 | - | |
| 433 | Ubiquitination | LINLVQGKDDNTSSA HHHHHCCCCCCCCCH | 44.83 | - | |
| 456 | Phosphorylation | LCGEEENSVHILDEK CCCCCCCCEEECCHH | 20.53 | 25159151 | |
| 465 | Phosphorylation | HILDEKLSDNFQDSE EECCHHHCCCCCCHH | 41.39 | 25159151 | |
| 550 | Ubiquitination | CEIGLEAKRVTLTPD CCEEEEEEEEEECCC | 37.72 | - | |
| 553 | Phosphorylation | GLEAKRVTLTPDSKK EEEEEEEEECCCCCC | 29.02 | 30266825 | |
| 555 | Phosphorylation | EAKRVTLTPDSKKEE EEEEEEECCCCCCCC | 18.71 | 30266825 | |
| 558 | Phosphorylation | RVTLTPDSKKEESFV EEEECCCCCCCCCCC | 46.99 | 30266825 | |
| 559 | Ubiquitination | VTLTPDSKKEESFVC EEECCCCCCCCCCCC | 72.14 | - | |
| 563 | Phosphorylation | PDSKKEESFVCEHPS CCCCCCCCCCCCCCC | 24.87 | 28555341 | |
| 623 | Phosphorylation | VCGRVFLSLEDLSTG EECEEEEEHHHCCCC | 20.46 | 26546556 | |
| 721 | Phosphorylation | EGILIIYSRNQTVMF EEEEEEEECCCEEHH | 17.85 | 24719451 | |
| 745 | Acetylation | LPINCFLKNLKSGSE HCHHHHHHCCCCCCC | 39.73 | 26051181 | |
| 748 | Ubiquitination | NCFLKNLKSGSENFL HHHHHCCCCCCCCEE | 63.26 | - | |
| 795 | Phosphorylation | CEVSKGKSSVVAAAL CEECCCCHHHHHHHH | 36.71 | - | |
| 796 | Phosphorylation | EVSKGKSSVVAAALS EECCCCHHHHHHHHH | 24.89 | 28555341 | |
| 803 | Phosphorylation | SVVAAALSDRRENIH HHHHHHHHCCHHHCH | 25.09 | - | |
| 831 | Phosphorylation | LQTNLKVSGALYREI HHHHHHHCHHHHHEE | 19.43 | 22210691 | |
| 835 | Phosphorylation | LKVSGALYREITLKV HHHCHHHHHEEEEEE | 12.98 | 22817900 | |
| 839 | Phosphorylation | GALYREITLKVAEVQ HHHHHEEEEEEEEEE | 18.77 | 22817900 | |
| 848 | Ubiquitination | KVAEVQLKSDFAAQK EEEEEEECHHHHHHH | 30.78 | - | |
| 855 | Ubiquitination | KSDFAAQKLSNL--- CHHHHHHHHHCC--- | 49.51 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FANCB_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FANCB_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FANCB_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FP100_HUMAN | C17orf70 | physical | 17396147 | |
| FANCA_HUMAN | FANCA | physical | 17396147 | |
| FANCL_HUMAN | FANCL | physical | 17396147 | |
| FANCM_HUMAN | FANCM | physical | 17396147 | |
| FANCG_HUMAN | FANCG | physical | 17396147 | |
| FANCL_HUMAN | FANCL | physical | 16720839 | |
| PP1R7_HUMAN | PPP1R7 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 300514 | Fanconi anemia complementation group B (FANCB) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-839, AND MASSSPECTROMETRY. | |